Deutsche Bank Raises Bar for SRT Leverage Amid ECB Inquiry
Deutsche Bank AG is tightening terms under which it provides loans for investors such as hedge funds to buy significant risk transfers.
The Frankfurt-based lender is letting investors in SRTs know that the bank will be less proactive in offering clients financing via repurchase agreements, according to people familiar with the matter.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a minute ago
- Business Wire
NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation
GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey's innovation economy—with Garden State Venture Partners (GSVP) emerging as a key catalyst behind both. These initiatives represent over $100 million in coordinated investment, a model of public-private partnership, and a strategic bet on New Jersey as the next national hub for health tech and equity-focused innovation. Share 1. MedTech Strategic Innovation Centers Backed by GSVP & NJEDA On July 21, NJEDA and Rowan University unveiled a major initiative to launch a Strategic Innovation Center, with locations in Camden and Mullica Hill, supporting early-stage medical technology companies with critical lab space, mentorship, and commercialization resources. GSVP, a New Jersey-based venture firm committed to fueling statewide innovation, is helping to make this possible through venture capital funding for early-stage medtech companies. Read release 2. A First-of-Its-Kind Maternal and Infant Health Innovation Center in Trenton Just one day later, Governor Murphy and First Lady Tammy Murphy broke ground on a Trenton-based center dedicated to maternal and infant health equity. The MedTech Strategic Innovation Center will also have a presence at the Maternal and Infant Health Innovation Center, which will focus on medical technologies that address racial disparities in care. Once again, GSVP will play a central role in helping bridge the gap between public health needs and private-sector innovation by accelerating promising, equity-driven health tech ventures. Read release Together, these initiatives represent over $100 million in coordinated investment, a model of public-private partnership, and a strategic bet on New Jersey as the next national hub for health tech and equity-focused innovation. GSVP's leadership and capital are essential to making that vision real. About Garden State Venture Partners Garden State Venture Partners (GSVP) is a next-gen venture capital firm built to attract and retain companies and talent within the state of New Jersey. GSVP is uniquely positioned to deepen existing partnerships and forge new ones across the state—catalyzing innovation and driving sustained economic success by connecting and investing in the state's innovation ecosystem. Learn more about GSVP at and access full leadership team bios here.
San Francisco Chronicle
a minute ago
- San Francisco Chronicle
PAMT: Q2 Earnings Snapshot
TONTITOWN, Ark. (AP) — TONTITOWN, Ark. (AP) — PAMT CORP (PAMT) on Friday reported a loss of $9.6 million in its second quarter. On a per-share basis, the Tontitown, Arkansas-based company said it had a loss of 46 cents. The trucking company posted revenue of $151.1 million in the period. _____
Miami Herald
22 minutes ago
- Miami Herald
Poppi soda drinkers could be owed part of $8.9M settlement. How to file a claim
Poppi's gut health claims fell flat with some consumers, and now the prebiotic soda brand will pay nearly $9 million in refunds. The Texas-based beverage company agreed to an $8.9 million settlement to resolve claims it improperly marketed its sodas as a 'gut healthy' alternative to traditional soft drinks, according to court documents. According to its website, Poppi was born in co-founder Allison Ellsworth's kitchen, where she mixed 'fruit juices with apple cider vinegar, prebiotics, and sparkling water.' Ellsworth went from selling her drinks at farmers markets to being featured on 'Shark Tank,' thrusting her soda brand into the national spotlight. A class-action complaint accused Poppi of claiming its sodas contain 'prebiotic fiber' but not enough to 'cause any meaningful gut health benefits.' McClatchy News reached out to Poppi for comment July 25 and was awaiting a response. 'Despite Defendant's alluring 'prebiotic' marketing claims, which assure consumers, on the can, that they can 'Be Gut Happy [and] Be Gut Healthy,' as one nutritionist bluntly explained: the Products 'are basically sugared water,' which has been shown to actually harm gut health,' the complaint says. Poppi has denied any wrongdoing. Here's what to know if you're owed: Who's eligible? Anyone in the U.S. who purchased Poppi beverages of any flavor and package size for personal use between Jan. 23, 2020, and July 18, 2025, is eligible to file a claim, settlement administrators said. How do I file a claim? Claim forms can be submitted online or printed and mailed, according to the settlement website. All claims must be submitted or postmarked no later than Friday, Sept. 26. How much is the payment? Poppi drinkers who submit a valid claim will be paid as follows: 75 cents per single can $3 per four-pack$6 per eight-pack$9 per 12- or 15-pack Customers without proof of purchase can receive up to $16 per household, administrators said. Final payment amounts may be higher or lower depending on the number of claims received. When will I be paid? A hearing to finalize the settlement is set for Nov. 20 in the U.S. District Court of the Northern District of California, and payments will be disbursed within 90 days, barring any appeals, administrators said. 'If the Court does not approve the Settlement, or if the Settlement is overturned on appeal, no Class Payments will be issued,' according to the website.
